Je veux savoir à propos de…

Federal Register / Vol. 86, No. 145 / Monday, August 2, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES

HHS-Certified Laboratories Approved To Conduct Urine Drug Testing In accordance with the Mandatory Guidelines using Urine dated January 23, 2017 82 FR 7920, the following HHS-certified laboratories meet the minimum standards to conduct drug and specimen validity tests on urine specimens:
Alere Toxicology Services, 1111 Newton St., Gretna, LA 70053, 5043618989/
8004333823 Formerly: Kroll Laboratory Specialists, Inc., Laboratory Specialists, Inc.
Alere Toxicology Services, 450
Southlake Blvd., Richmond, VA
23236, 8043789130 Formerly:
Kroll Laboratory Specialists, Inc., Scientific Testing Laboratories, Inc.;
Kroll Scientific Testing Laboratories, Inc.
Clinical Reference Laboratory, Inc., 8433
Quivira Road, Lenexa, KS 66215
2802, 8004456917
Cordant Health Solutions, 2617 East L
Street, Tacoma, WA 98421, 800442
0438 Formerly: STERLING Reference Laboratories Desert Tox, LLC, 5425 E Bell Rd, Suite 125, Scottsdale, AZ 85254, 602457
5411/6237485045
DrugScan, Inc., 200 Precision Road, Suite 200, Horsham, PA 19044, 800
2354890
Dynacare, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519
6791630 Formerly: GammaDynacare Medical Laboratories ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662
2362609
Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 7138568288/
8008002387, Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ
08869, 9085262400/8004374986
Formerly: Roche Biomedical Laboratories, Inc.
Laboratory Corporation of America Holdings, 1904 TW Alexander Drive, Research Triangle Park, NC 27709, 9195726900/8008333984
Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A
Member of the Roche Group Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 8668278042/
8002336339 Formerly: LabCorp Occupational Testing Services, Inc.;
MedExpress/National Laboratory Center
VerDate Sep<11>2014

17:21 Jul 30, 2021

Jkt 253001

LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS
66219, 9138883927/8008738845
Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.
Legacy Laboratory Services Toxicology, 1225 NE 2nd Ave., Portland, OR
97232, 5034135295/8009505295
MedTox Laboratories, Inc., 402 W.
County Road D, St. Paul, MN 55112, 6516367466/8008323244
Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612725
2088, Testing for Veterans Affairs VA Employees Only Pacific Toxicology Laboratories, 9348
DeSoto Ave., Chatsworth, CA 91311, 8003286942 Formerly: Centinela Hospital Airport Toxicology Laboratory Phamatech, Inc., 15175 Innovation Drive, San Diego, CA 92128, 888
6355840
Quest Diagnostics Incorporated, 400
Egypt Road, Norristown, PA 19403, 6106314600/8776422216
Formerly: SmithKline Beecham Clinical Laboratories; SmithKline BioScience Laboratories Redwood Toxicology Laboratory, 3700
Westwind Blvd., Santa Rosa, CA
95403, 8002552159
US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755
5235, 3016777085, Testing for Department of Defense DoD
Employees Only The Standards Council of Canada SCC voted to end its Laboratory Accreditation Program for Substance Abuse LAPSA effective May 12, 1998.
Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation DOT regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP
may apply directly to the NLCP
contractor just as U.S. laboratories do.
Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory Federal
PO 00000

Frm 00059

Fmt 4703

Sfmt 4703

41491

Register, July 16, 1996 as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on January 23, 2017 82 FR
7920. After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP
certification maintenance program.
Anastasia Marie Donovan, Policy Analyst, Division of Workplace Programs.
FR Doc. 202116385 Filed 73021; 8:45 am BILLING CODE 416020P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health Services Administration Agency Information Collection Activities: Proposed Collection;
Comment Request In compliance with Section 3506c2A of the Paperwork Reduction Act of 1995 concerning opportunity for public comment on proposed collections of information, the Substance Abuse and Mental Health Services Administration SAMHSA
will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the information collection plans, call the SAMHSA
Reports Clearance Officer at 240 276
0361.
Comments are invited on: a Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;
b the accuracy of the agencys estimate of the burden of the proposed collection of information; c ways to enhance the quality, utility, and clarity of the information to be collected; and d ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology.
Proposed Project: Government Performance and Results Act GPRA
Client/Participant Outcomes Measure OMB No. 09300208Revision SAMHSA is requesting approval to modify its existing CSAT Client-level GPRA instrument by removing 40
questions and adding 41 questions to its existing CSAT Client-level GPRA
instrument resulting in a net addition of 1 question. Currently, the information collected from this instrument is
E:FRFM02AUN1.SGM

02AUN1